Gabriele Corso was a computer science PhD student at MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL), where his research focused on the intersection of machine learning and molecular biology. His cofounder Saro Passaro was also a research scientist at MIT and previously worked at Meta. The two have trained AI models for predicting biomolecular structures and how molecules interact within the body, which could eventually help with drug discovery. Used by thousands of global organizations and downloaded more than 1M times, these open source models are the basis for Boltz, a company Corso and Passaro cofounded with Jeremy Wohlwend to improve therapeutic design using AI. Learn more
More than 300 people across academia and industry spilled into an auditorium to attend a BoltzGen seminar on Thursday, Oct. 30, hosted by the Abdul Latif Jameel Clinic for Machine Learning in Health (MIT Jameel Clinic). Headlining the event was MIT PhD student and BoltzGen’s first author Hannes Stärk, who had announced BoltzGen just a few days prior. Learn more
